Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Cui, Huaqing ^a   Wu, Feng ^a   Sun, Yanling ^b   Fan, Guocai ^a   Wang, Qingming ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B1; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2 B1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2-B1; MESSENGER RNA; TUMOR MARKER;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIGEN RECOGNITION; ARTICLE; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; CELL NUCLEUS; CYTOPLASM; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; LIVER CELL; LIVER TUMOR; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; WESTERN BLOTTING; WISTAR RAT;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEPATOCYTES; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SINGLE-CHAIN ANTIBODIES; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77954194473     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-356     Document Type: Article

References (49)

1. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004, 127:S5-S16. 10.1053/j.gastro.2004.09.011, 15508102.
2. Gomaa AI, Khan SA, Leen ELS, Waked I, Taylor-Robinson SD. Diagnosis of hepatocellular carcinoma. World J Gastroentero 2009, 15:1301-1314.
3. Kaseb AO, Hanbali A, Cotant M, Hassan MM, Wollner I, Philip PA. Vascular Endothelial Growth Factor in the Management of Hepatocellular Carcinoma A Review of Literature. Cancer 2009, 115:4895-4906. 10.1002/cncr.24537, 19637355.
4. Nian H, An L, Zhao Y, Chen J, Fan G, Wang Q. Construction and screening of Anti-Hepatoma Cells phage display scFv library. Current Immunolugy (Chinese) 2004, 24:357-361.
5. Kozu T, Henrich B, Schafer KP. Structure and Expression of the Gene (Hnrpa2b1) Encoding the Human Hnrnp Protein A2/B1. Genomics 1995, 25:365-371. 10.1016/0888-7543(95)80035-K, 7789969.
6. Carpenter B, MacKay C, Alnabulsi A, MacKay M, Telfer C, Melvin WT, Murray GI. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. BBA-Rev Cancer 2006, 1765:85-100.
7. Zhou J, Mulshine JL, Unsworth EJ, Scott FR, Avis IM, Vos MD, Treston AM. Purification and characterization of a protein that permits early detection of lung cancer - Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4. J Bio Chem 1996, 271:10760-10766.
8. Gao JN, Gao Y, Ju YF, Yang JJ, Wu Q, Zhang JC, Du XM, Wang ZQ, Song YB, Li H, et al. Proteomics-based generation and characterization of monoclonal antibodies against human liver mitochondrial proteins. Proteomics 2006, 6:427-437. 10.1002/pmic.200500409, 16342244.
9. Fielding P, Turnbull L, Prime W, Walshaw M, Field JK. Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: A clinical marker of early lung cancer detection. Clin Cancer Res 1999, 5:4048-4052.
10. Wang X, Peng XD, Li G, Hu LJ, Bi JH. Cloning, ligation and expression of the variable region genes of the monoclonal antibody against human HnRNPA2/B1. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2004, 21:548-551.
11. Ushigome M, Ubagai T, Fukuda H, Tsuchiya N, Sugimura T, Takatsuka J, Nakagama H. Up-regulation of hnRNP A1 gene in sporadic human colorectal cancers. Int J Oncol 2005, 26:635-640.
12. Zhou J, Allred DC, Avis I, Martinez A, Vos MD, Smith L, Treston AM, Mulshine JL. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Tr 2001, 66:217-224.
13. Yan-Sanders Y, Hammons GJ, Lyn-Cook BD. Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells. Cancer Lett 2002, 183:215-220. 10.1016/S0304-3835(02)00168-4, 12065097.
14. Lee CH, Lum JHK, Cheung BPY, Wong MS, Butt YKC, Tam MF, Chan WY, Chow C, Hui PK, Kwok FSL, et al. Identification of the heterogeneous nuclear ribonucleoprotein A2/B1 as the antigen for the gastrointestinal cancer specific monoclonal antibody MG7. Proteomics 2005, 5:1160-1166. 10.1002/pmic.200401159, 15759317.
15. Kamma H, Horiguchi H, Wan LL, Matsui M, Fujiwara M, Fujimoto M, Yazawa T, Dreyfuss G. Molecular characterization of the hnRNP A2/B1 proteins: Tissue-specific expression and novel isoforms. Exp Cell Res 1999, 246:399-411. 10.1006/excr.1998.4323, 9925756.
16. Nichols RC, Wang XW, Tang J, Hamilton BJ, High FA, Herschman HR, Rigby WFC. The RGG domain in hnRNP A2 affects subcellular localization. Exp Cell Res 2000, 256:522-532. 10.1006/excr.2000.4827, 10772824.
17. Man YG, Martinez A, Avis IM, Hong SH, Cuttitta F, Venzon DJ, Mulshine JL. Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations. Am J Res Cell Mol 2000, 23:636-645.
18. Montuenga LM, Zhou J, Avis I, Vos M, Martinez A, Cuttitta F, Treston AM, Sunday M, Mulshine JL. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 changes with critical stages of mammalian lung development. Am J Res Cell Mol 1998, 19:554-562.
19. Edmondson H, Steiner P. Primary Carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 1954, 7:462-503. 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E, 13160935.
20. Xiao T, Ying WT, Li L, Hu Z, Ma Y, Jiao LY, Ma JF, Cai Y, Lin DM, Guo SP, et al. An approach to studying lung cancer-related proteins in human blood. Mol Cell Proteomics 2005, 4:1480-1486. 10.1074/mcp.M500055-MCP200, 15970581.
21. Ling Y, Mengxue Y, Hongen Y, Jiayou L, Yang G, Xiaxiu H. The clone, expression, purification and clinical application of hnRNP A2/B1. Chinese Journal of Microbiology and Immunology 2002, 22:4.
22. He YW, Brown MA, Rothnagel JA, Saunders NA, Smith R. Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation. J Cell Sci 2005, 118:3173-3183. 10.1242/jcs.02448, 16014382.
23. David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 2010, 463:364-U114. 10.1038/nature08697, 20010808.
24. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-U274. 10.1038/nature06734, 18337823.
25. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314. 10.1126/science.123.3191.309, 13298683.
26. Heiden MGV, Cantley LC, Thompson CB. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science 2009, 324:1029-1033. 2849637, 19460998, 10.1126/science.1160809.
27. Wang T, Marquardt C, Foker J. Aerobic Glycolysis during Lymphocyte-Proliferation. Nature 1976, 261:702-705. 10.1038/261702a0, 934318.
28. Zhou J, Mulshine JL, Ro JY, Avis I, Yu R, Lee JJ, Morice R, Lippman SM, Lee JS. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clin Cancer Res 1998, 4:1631-1640.
29. Fung J, Lai CL, Yuen MF. Hepatitis B and C virus-related carcinogenesis. Clin Microbiol Infect 2009, 15:964-970. 10.1111/j.1469-0691.2009.03035.x, 19874379.
30. Takao J, Ariizumi K, Dougherty II, Cruz PD. Genomic scale analysis of the human keratinocyte response to broad-band ultraviolet-B irradiation. Photodermatol Photo 2002, 18:5-13.
31. Iwanaga K, Sueoka N, Sato A, Hayashi S, Sueoka E. Heterogeneous nuclear ribonucleoprotein B1 protein impairs DNA repair mediated through the inhibition of DNA-dependent protein kinase activity. Biochem Bioph Res Co 2005, 333:888-895.
32. Wu SL, Sato M, Endo C, Sakurada A, Dong BM, Aikawa H, Chen Y, Okada Y, Matsumura Y, Sueoka E, Kondo T. hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung. Lung Cancer 2003, 41:179-186. 10.1016/S0169-5002(03)00226-5, 12871781.
33. He Y, JAR, Epis MR, Leedman PJ, Smith R. Downstream targets of heterogeneous nuclear ribonucleoprotein A2 mediate cell proliferation. Mol Carcinogen 2008, 48:167-179.
34. He Y, Brown MA, Rothnagel JA, Saunders NA, Smith R. Roles of heterogeneous nuclear ribonucleoproteins A/B in cell growth. Mol Biol Cell 2004, 15:252A-253A.
35. Lee CL, Hsiao HH, Lin CW, Wu SP, Huang SY, Wu CY, Wang AHJ, Khoo KH. Strategic shotgun proteomics approach for efficient construction of an expression map of targeted protein families in hepatoma cell lines. Proteomics 2003, 3:2472-2486. 10.1002/pmic.200300586, 14673797.
36. Kupfer A, Louvard D, Singer SJ. Polarization of the Golgi-Apparatus and the Microtubule-Organizing Center in Cultured Fibroblasts at the Edge of an Experimental Wound. P Natl A Sci USA-Biol 1982, 79:2603-2607.
37. Moran-Jones K, Grindlay J, Jones M, Smith R, Norman JC. hnRNP A2 Regulates Alternative mRNA Splicing of TP53INP2 to Control Invasive Cell Migration. Cancer Res 2009, 69:9219-9227. 10.1158/0008-5472.CAN-09-1852, 19934309.
38. Amuthan G, Biswas G, Zhang SY, Klein-Szanto A, Vijayasarathy C, Avadhani NG. Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. Embo J 2001, 20:1910-1920. 125420, 11296224, 10.1093/emboj/20.8.1910.
39. Guha M, Pan H, Fang JK, Avadhani NG. Heterogeneous Nuclear Ribonucleoprotein A2 Is a Common Transcriptional Coactivator in the Nuclear Transcription Response to Mitochondrial Respiratory Stress. Mol Biol Cell 2009, 20:4107-4119. 2743628, 19641020, 10.1091/mbc.E09-04-0296.
40. Kojiro M, Nakashima O. Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis 1999, 19:287-296. 10.1055/s-2007-1007118, 10518308.
41. Kamma H, Satoh H, Matusi M, Wu WW, Fujiwara M, Horiguchi H. Characterization of hnRNP A2 and B1 using monoclonal antibodies: intracellular distribution and metabolism through cell cycle. Immunol Lett 2001, 76:49-54. 10.1016/S0165-2478(00)00318-7, 11222913.
42. Ma KW, Au SWN, Waye MMY. Over-expression of SUMO-1 induces the up-regulation of heterogeneous nuclear ribonucleoprotein A2/B1 isoform B1 (hnRNP A2/B1 isoform B1) and uracil DNA glycosylase (UDG) in hepG2 cells. Cell Biochem Funct 2009, 27:228-237. 10.1002/cbf.1562, 19384898.
43. Pioli PA, Rigby WFC. The von Hhippel-Lindau protein interacts with heteronuclear ribonucleoprotein A2 and regulates its expression. J Bio Chem 2001, 276:40346-40352.
44. Diamandis EP, Fritsche HA, Lilja H, Chan DW, Schwart MK. Tumor Markers: Physiology, Pathobiology, Technology and Clinical Application 2002, Washington DC: AACC press.
45. Bosser R, Faura M, Serratosa J, Renaupiqueras J, Pruschy M, Bachs O. Phosphorylation of Rat-Liver Heterogeneous Nuclear Ribonucleoprotein-A2 and Ribonucleoprotein-C Can Be Modulated by Calmodulin. Mol Cell Biol 1995, 15:661-670. 231926, 7823935.
46. Hiraki A, Murakami T, Aoe K, Sueoka E, Sueoka N, Taguchi K, Kamei T, Sugi K, Ueoka H, Kishimoto T. Heterogeneous nuclear ribonucleoprotein B1 expression in malignant mesothelioma. Cancer Sci 2006, 97:1175-1181. 10.1111/j.1349-7006.2006.00311.x, 16939492.
47. Sueoka E, Sueoka N, Goto Y, Matsuyama S, Nishimura H, Sato M, Fujimura S, Chiba H, Fujiki H. Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia. Cancer Res 2001, 61:1896-1902.
48. Tani H, Ohshima K, Haraoka S, Hamasaki M, Kamma H, Ikeda S, Kikuchi M. Reduced expression of heterogeneous nuclear ribonucleoprotein B1 in adult T-cell lymphoma/leukemia. Int J Oncol 2003, 22:529-534.
49. Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T, Fujiki H. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res 1999, 59:1404-1407.